Skip to main content

Animations

MJFF Publications

7811 - 7820 of 8621 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Physical inactivity is associated with Parkinson's disease mild cognitive impairment and dementia
    Journal Name: Mental Health and Physical Activity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.mhpa.2022.100461
    Citation Count: 10
  • Summary Details
    RESTRICTED
    Title: Olfaction and apathy in early idiopathic Parkinson's disease
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2022.120314
    Best OA location URL:
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Structure-constrained combination-based nonlinear association analysis between incomplete multimodal imaging and genetic data for biomarker detection of neurodegenerative diseases
    Journal Name: Medical Image Analysis
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.media.2022.102419
    Best OA location URL:
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.molcel.2021.11.012
    Citation Count: 82
  • Summary Details
    OPEN
    Title: Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.molcel.2022.06.005
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Detection of emerging neurodegeneration using Bayesian linear mixed-effect modeling
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nicl.2022.103144
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Racial disparities in hypertension management among multiple sclerosis patients
    Journal Name: Multiple Sclerosis and Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.msard.2022.103972
    Citation Count: 10
  • Summary Details
    OPEN
    Title: NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson’s disease using convolutional neural network
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2022.103250
    Citation Count: 12
  • Summary Details
    OPEN
    Title: DARQ: Deep learning of quality control for stereotaxic registration of human brain MRI to the T1w MNI-ICBM 152 template
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2022.119266
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2022.103022
    Citation Count: 27
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.